Who owns TVARDI THERAPEUTICS INC?
- Ticker: TVRD
- CUSIP Number: 140755307
Tip: Access positions for across all investors
Analyze quarterly positions in Tvardi Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tvardi Therapeutics stock
Who bought or sold TVARDI THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Slate Path Capital | 704k | $3.0M | 0% | Dec 2025 |
|
| Vanguard Group | 425k | $1.8M | 1% | Dec 2025 |
|
| BlackRock | 391k | $1.7M | 19% | Dec 2025 |
|
| American Financial Group | 224k | $962k | 100% | Dec 2025 |
|
| Geode Capital Management | 157k | $676k | 6% | Dec 2025 |
|
| State Street Corporation | 116k | $497k | 84% | Dec 2025 |
|
| Renaissance Technologies | 105k | $449k | 246% | Dec 2025 |
|
| FMR | 82k | $3.2M | 1644320% | Sep 2025 |
|
| Duncan Williams Asset Management | 81k | $312k | 100% | Dec 2025 |
|
| Squarepoint Ops | 52k | $223k | 534% | Dec 2025 |
|
| Northern Trust | 48k | $206k | 13% | Dec 2025 |
|
| Jane Street | 47k | $204k | 100% | Dec 2025 |
|
| Farallon Capital Management | 43k | $186k | 0% | Dec 2025 |
|
| UBS Group | 36k | $154k | -27% | Dec 2025 |
|
| Goldman Sachs Group | 33k | $143k | 38% | Dec 2025 |
|
| Silvercrest Asset Management Group | 22k | $872k | 100% | Sep 2025 |
|
| Quadrature Capital | 21k | $90k | 100% | Dec 2025 |
|
| Bank of New York Mellon | 18k | $78k | 88% | Dec 2025 |
|
| Russell Investments | 16k | $69k | 1351% | Dec 2025 |
|
| XTX Topco | 13k | $55k | 100% | Dec 2025 |
|
| Charles Schwab Investment Management | 12k | $51k | -23% | Dec 2025 |
|
| Hrt Financial | 11k | $47k | 100% | Dec 2025 |
|
| SRS Capital Advisors | 8.4k | $36k | 277% | Dec 2025 |
|
| Barclays | 8.3k | $36k | 25% | Dec 2025 |
|
| Wells Fargo & Company | 6.0k | $26k | 70% | Dec 2025 |
|
| Rhumbline Advisers | 3.1k | $13k | -21% | Dec 2025 |
|
| Deutsche Bank Aktiengesellschaft | 3.0k | $13k | 0% | Dec 2025 |
|
| New York State Common Retirement Fund | 3.0k | $13k | 0% | Dec 2025 |
|
| Royal Bank of Canada | 2.7k | $107k | 903% | Sep 2025 |
|
| Tower Research Capital | 2.5k | $11k | 615% | Dec 2025 |
|
| Mirae Asset Global Etfs Holdings | 2.3k | $9.8k | 4% | Dec 2025 |
|
| Jpmorgan Chase & Co | 1.9k | $75k | 100% | Sep 2025 |
|
| Simplex Trading | 1.4k | $6.1k | -53% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.3k | $5.4k | 11% | Dec 2025 |
|
| Police & Firemen's Retirement System of New Jersey | 916.00 | $3.9k | 0% | Dec 2025 |
|
| Legal & General Group | 421.00 | $1.8k | 0% | Dec 2025 |
|
| Summit Investment Advisors | 349.00 | $1.5k | 0% | Dec 2025 |
|
| California State Teachers Retirement System | 331.00 | $1.4k | 55% | Dec 2025 |
|
| Pnc Financial Services | 294.00 | $1.3k | 512% | Dec 2025 |
|
| Sterling Capital Management | 292.00 | $1.3k | 1% | Dec 2025 |
|
| CWM | 206.00 | $1.0k | 4020% | Dec 2025 |
|
| Amalgamated Bank | 169.00 | $1.0k | 44% | Dec 2025 |
|
| Hanson McClain Advisors | 141.00 | $607.005000 | 642% | Dec 2025 |
|
| Jones Financial Companies, L.L | 125.00 | $538.000000 | 400% | Dec 2025 |
|
| Group One Trading | 114.00 | $489.994800 | 714% | Dec 2025 |
|
| Advisor Group Holdings | 29.00 | $123.000600 | 0% | Dec 2025 |
|
| LRI Investments | 27.00 | $116.000100 | 100% | Dec 2025 |
|
| McIlrath & Eck | 20.00 | $86.000000 | 0% | Dec 2025 |
|
| Harbour Investments | 15.00 | $64.999500 | 0% | Dec 2025 |
|
| Leonteq Securities | 12.00 | $51.999600 | 100% | Dec 2025 |
|
| MAI Wealth Advisors | 10.00 | $43.000000 | 0% | Dec 2025 |
|
| IFP Advisors | 6.00 | $25.999800 | 100% | Dec 2025 |
|
| International Assets Investment Management | 6.00 | $25.999800 | 100% | Dec 2025 |
|
| EverSource Wealth Advisors | 5.00 | $22.000000 | 100% | Dec 2025 |
|
| Truvestments Capital | 4.00 | $17.000000 | 0% | Dec 2025 |
|
| SBI Securities | 4.00 | $17.000000 | 0% | Dec 2025 |
|
| Larson Financial Group | 2.00 | $9.000000 | 100% | Dec 2025 |
|
| Brian McDonald | 1.00 | $4.000000 | 0% | Dec 2025 |
|
| Front Row Advisors | 1.00 | $4.000000 | 100% | Dec 2025 |
|
| Cornerstone Planning Group | 1.00 | $4.000000 | 100% | Dec 2025 |
|
Who sold out of Tvardi Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| 683 Capital Management | Sep 2025 | 176k | $6.8M |
| Vestal Point Capital | Sep 2025 | 167k | $6.5M |
| Invesco | Sep 2025 | 83k | $3.2M |
| Parkman Healthcare Partners | Sep 2025 | 65k | $2.5M |
| Boothbay Fund Management | Sep 2025 | 27k | $1.1M |
| Schonfeld Strategic Advisors | Sep 2025 | 19k | $746k |
| Ikarian Capital | Sep 2025 | 19k | $740k |
| Monaco Asset Management SAM | Sep 2025 | 14k | $530k |
| Nuveen | Sep 2025 | 6.0k | $232k |
| MetLife Investment Advisors | Sep 2025 | 2.8k | $110k |
| Caption Management | Sep 2025 | 2.4k | $94k |
| Diadema Partners | Sep 2025 | 2.2k | $85k |
| State of Wyoming | Sep 2025 | 1.3k | $46k |
| China Universal Asset Management | Sep 2025 | 1.0k | $39k |
| Persistent Asset Partners | Sep 2025 | 500.00 | $20k |
| Goss Wealth Management | Sep 2025 | 8.00 | $312.000000 |
| Rockefeller Capital Management | Sep 2025 | 4.00 | $156.000000 |